Skip to main content
. 2009 May 8;284(19):12905–12916. doi: 10.1074/jbc.M900280200

TABLE 4.

Tumor pharmacokinetics of free doxorubicin versus liposomal doxorubicin formulations

Formulation (2 mg/kg) Tumor AUC0–48 h Nucleus AUC0–48 h
μg·h/g μg·h/g
Free doxorubicin 10.23 3.68
Liposomal doxorubicin 31.25 6.71
PIVO-8-LD 49.63 14.76
PIVO-24-LD 49.49 13.94